Overview
Verne Robotics provides AI-powered software for bimanual robot arms to learn and perform new tasks within hours, not weeks. Its Nemo3 system—a dual-arm robot with a 2.5-foot reach and 4-pound payload—uses AI and diffusion models to analyze about 30 minutes of tele-operated data and break tasks into learnable skills that the robot can execute. The company offers a pay-by-the-hour model, avoiding large upfront costs and making automation accessible to industries that require dexterous manipulation, such as meal-kit assembly, packaging, logistics, and biotech lab work. Verne Robotics differentiates itself through fast, data-driven task learning, flexible installation, and a service-based pricing approach rather than traditional, expensive robotic deployments. Its goal is to accelerate and democratize robotic automation by enabling rapid, flexible, and affordable robotic solutions that can be deployed in a variety of settings.
Work here?Claim your company
Simplify's take
What believers are saying
- YC S25 visibility and August 2026 team growth indicate continued investor interest.
- Biotech unicorn and ABClonal references prove credible early production demand.
- November 2026 market chatter still highlights rapid setup and weekend deployment speed.
What critics are saying
- Four-person team and 2026 hiring updates still signal fragile execution capacity.
- Customer mix includes niche biotech and apparel, risking slow repeatable sales cycles.
- Nemo3's 4-pound payload and 2.5-foot reach limit jobs versus larger incumbents.
What makes Verne Robotics unique
- YC S25 Verne Robotics sells pay-by-the-hour robot arms, not heavy capex hardware.
- Nemo3 learns new tasks from 30 minutes of tele-operated data in hours.
- ABClonal deployed production automation in four days for chemical vial packaging.
Help us improve and share your feedback! Did you find this helpful?
Funding
Industry standards